Official UK procurement notice
BLMK ICB Direct Oral Anticoagulant (DOAC) Medication Review Service
Authority: NHS Bedfordshire, Luton and Milton Keynes Integrated Care Board (Central government)
What is being bought
Published requirement descriptionThe Direct Oral Anticoagulant (DOAC) medication review service will assist Bedfordshire, Luton and Milton Keynes (BLMK) GP practices to deliver a high quality and safe DOAC review and change programme.
CPV: General-practitioner services · Health services
The lotProcurement structure
single lot · no lot value publishedLot #1The Direct Oral Anticoagulant (DOAC) medication review service will be delivered by…Awarded
The Direct Oral Anticoagulant (DOAC) medication review service will be delivered by provider employed non-medical prescribing pharmacist with clinical expertise in DOAC prescribing and experience of undertaken similar DOAC review and change programmes. Identifying, reviewing and where appropriate and with patients consent initiating/prescribing a cost-effective DOAC for the patient. <br/><br/>The contact has been awarded following direct award process A with a maximum contract value £165,000 based on £550 per clinical day (7.5hrs) and the contract value is activity related. The contract is for a period of 4 months from 1st September 2025 to 31st December 2025 with an option to extend for a period of up to 3months i.e. 31st March 2026, if required within the specified financial envelope.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 12 Aug 2025, 16:24 BST
- Last source update
- 18 Aug 2025, 10:16 BST
- FTS notice number
2025/S 000-049369- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05867dFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
No realistic alternative provider.
Publisher note: This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.<br/><br/>There is a risk of a significant cost pressure to the BLMK ICB prescribing budget through the anticipated loss of a commercial agreement within direct oral anticoagulants (DOACs) prescribing. As a risk mitigation, people on edoxaban within BLMK will be reviewed and where clinically appropriate and with patient consent changed to the most cost-effective DOACs, as identified in NHSE DOAC Commissioning Guidance.<br/><br/>An additional financial risks exists to the BLMK ICB prescribing budget if the review and change programme does not happen at the scale and pace that is required to mitigate loss of the commercial agreement. GP pressures and workforce capacity limitations, means a 3rd party clinical provider with expertise in DOAC prescribing and experience of safely undertaking a DOAC review and change programme is required. Due to the imminent cost pressure there is a need to mobilise the service by 1st September 2025.<br/><br/>The BLMK ICB Chiefs (Executives) gave approval of this in August 2025 at the scheduled Investment Oversight Group Meeting. Conflicts of interest have been managed in line with the ICB's Conflict of Interest and Standards of Business Conduct Policy.
Notice history
2 releases on Find a TenderPublished amendments (1)
Please note that the contract for this service has been awarded to Spirit Implement Limited (Companies House registration number 07300197) and not Spirit Healthcare Ltd (Companies House registration number 06259954). This was selected inadvertently as both organisations are registered at the same address i.e. Spirit House, Saffron Way, Leicester, LE2 6UP. All other elements of the award remain the…
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Spirit Healthcare LtdSME | £165,000 † | — | Awarded |
Contracts
Contract 048165-2025-1 · Spirit Healthcare LtdSME
- Signed
- 7 Aug 2025
- Value
- £165,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- NHS EnglandReview body
Bidders & participating suppliers
1 commercial party on the notice- Spirit Healthcare LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.